BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27867568)

  • 1. The overexpression of KIFC1 was associated with the proliferation and prognosis of non-small cell lung cancer.
    Liu Y; Zhan P; Zhou Z; Xing Z; Zhu S; Ma C; Li Q; Zhu Q; Miao Y; Zhang J; Lv T; Song Y
    J Thorac Dis; 2016 Oct; 8(10):2911-2923. PubMed ID: 27867568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Roles of KIFC1 in the Development of Osteosarcoma: Characterization of Potential Therapeutic Targets.
    Liang LY; Li GS
    Comput Math Methods Med; 2022; 2022():5039134. PubMed ID: 35479190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of KIFC1 is a poor prognostic biomarker and correlates with TP53 mutation in lung cancer.
    Li X; Wang S; Ruan P; Bajinka O; Zhang W
    Medicine (Baltimore); 2024 Mar; 103(10):e37286. PubMed ID: 38457554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIFC1 promotes the proliferation of hepatocellular carcinoma
    Wang X; Wang M; Li XY; Li J; Zhao DP
    Oncol Lett; 2019 Dec; 18(6):5739-5746. PubMed ID: 31788047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation of KIFC1 gene in determination of histological diagnosis, prognosis and metastasis of lung cancer.
    Celik B; Pasin O; Sen S; Tuncer SB; Kayım ZY; Erciyas SK; Erdogan OS; Gultaslar BK; Ghafour AA; Yazıcı H; Olgac NV
    Pathol Res Pract; 2023 Sep; 249():154742. PubMed ID: 37666088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-135a acts as a tumor suppressor in gastric cancer in part by targeting KIFC1.
    Zhang C; Chen X; Chen X; Wang X; Ji A; Jiang L; Sang F; Li F
    Onco Targets Ther; 2016; 9():3555-63. PubMed ID: 27366092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIFC1 promotes aerobic glycolysis in endometrial cancer cells by regulating the c-myc pathway.
    Zhou K; Lin J; Dai M; He Y; Xu J; Lin Q
    J Bioenerg Biomembr; 2021 Dec; 53(6):703-713. PubMed ID: 34729671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and clinicopathological significance of kinesin family member C1 in various cancers: A meta-analysis.
    Sun Y; Zhang Y; Lang Z; Huang J; Zou Z
    Medicine (Baltimore); 2019 Oct; 98(40):e17346. PubMed ID: 31577729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Expression of KIFC1 in Glioma Correlates with Poor Prognosis.
    Xue P; Zheng J; Li R; Yan L; Wang Z; Jia Q; Zhang L; Li X
    J Korean Neurosurg Soc; 2024 May; 67(3):364-375. PubMed ID: 38720546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDK1 promotes the phosphorylation of KIFC1 to regulate the tumorgenicity of endometrial carcinoma.
    Lin X; He Y; Liu Y; Zhou H; Xu X; Xu J; Zhou K
    J Gynecol Oncol; 2024 Feb; ():. PubMed ID: 38456590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinesin Family Member C1 (KIFC1/HSET): A Potential Actionable Biomarker of Early Stage Breast Tumorigenesis and Progression of High-Risk Lesions.
    Wright N; Gong Z; Kittles R; Natarajan R; Jovanovic-Talisman T; Rida P; LaBarge M; Seewaldt V
    J Pers Med; 2021 Dec; 11(12):. PubMed ID: 34945833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive analysis of the prognostic and immunotherapeutic characteristics of KIFC1 in pan-cancer and its role in the malignant phenotype of pancreatic cancer.
    Zhang S; Qin O; Xu H; Wu S; Huang W; Song H
    Aging (Albany NY); 2023 Dec; 15(24):14845-14863. PubMed ID: 38112634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
    Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
    Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non-small cell lung cancer cell proliferation by epigenetically repressing p21 expression.
    Yin D; Lu X; Su J; He X; De W; Yang J; Li W; Han L; Zhang E
    Mol Cancer; 2018 May; 17(1):92. PubMed ID: 29793547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High KIFC1 expression is associated with poor prognosis in prostate cancer.
    Kostecka LG; Olseen A; Kang K; Torga G; Pienta KJ; Amend SR
    Med Oncol; 2021 Mar; 38(5):47. PubMed ID: 33760984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of kinesin motor protein KIFC1 by AZ82 induces multipolar mitosis and apoptosis in prostate cancer cell.
    Parvin A; Hao SL; Tan FQ; Yang WX
    Gene; 2020 Nov; 760():144989. PubMed ID: 32717307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2.
    Cai F; Zhu Q; Miao Y; Shen S; Su X; Shi Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):59-69. PubMed ID: 27629878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KIFC1 is a novel potential therapeutic target for breast cancer.
    Li Y; Lu W; Chen D; Boohaker RJ; Zhai L; Padmalayam I; Wennerberg K; Xu B; Zhang W
    Cancer Biol Ther; 2015; 16(9):1316-22. PubMed ID: 26177331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIFC1 Inhibitor CW069 Induces Apoptosis and Reverses Resistance to Docetaxel in Prostate Cancer.
    Sekino Y; Oue N; Koike Y; Shigematsu Y; Sakamoto N; Sentani K; Teishima J; Shiota M; Matsubara A; Yasui W
    J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30744126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.